Search / Trial NCT06229002

Effect of Transcranial Alternative Current Stimulation at Alpha Frequency (α-tACS) on Stressed Healthy Subjects

Launched by HÔPITAL LE VINATIER · Jan 25, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Description

The study will focus on the effect of tACS at alpha frequency (α-tACS), delivered on the dorsolateral prefrontal cortex, on the response to a stress factor. In this study, while receiving a single α-tACS session, the participants will complete a standardized stress test combining cognitive stress (mental calculation) and physical stress (cold pressure): the Maastricht Acute Stress Test. The main objective aims at assessing the effect of a single session of tACS at alpha frequency, delivered on the dorsolateral prefrontal cortex, on the cortisol reactivity in healthy stressed subjects. In t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Right-handed Men and Women aged between 18 and 45
  • * If woman, hormonal contraception required
  • * Having given their written informed consent
  • * Affiliated with a social security scheme
  • * French speakers and readers
  • Exclusion Criteria:
  • * Contraindication to the exposure to exposure to tACS
  • * Current psychiatric disorder as classified in the DSM-5
  • * Regular intake of any psychotropic drug or Beta Blocker
  • * Recent exposure to a traumatic event
  • * Any debilitating condition making the experimental procedure not feasible
  • * Pregnancy

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Bron, Aura, France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0